Europe Biomaterials in Healthcare Market Analysis

Europe Biomaterials in Healthcare Market Analysis


$ 3999

This report presents a strategic analysis of the Europe Biomaterials in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Europe Biomaterials in Healthcare Market, offering unmatched value, accuracy and expert insights.

ID: IN10EUMD003 CATEGORY: Medical Devices GEOGRAPHY: Europe

Buy Now

Europe Biomaterials in Healthcare Market Executive Summary

The European Union's fastest-growing economy in 2021 was Ireland, with the country's GDP growing by 13.5 percent that year. With a GDP of almost 3.3 trillion Euros, Germany is by far Europe's largest economy, followed by the United Kingdom at 2.28 trillion Euros and France at 2.27 trillion Euros.

Despite the fact that unemployment in the EU is currently low, the inflation rate hit a new high of 7.8% in March 2022. Going into 2022, Europe's growth rate is anticipated to be 2.7 percent, with Portugal having the fastest growth rate of 5.8 percent and Estonia having the slowest growth rate of one percent.

To develop universal health care, deal with medical emergencies, and encourage healthier populations, access to high-quality, reasonably priced, and suitable health products is essential.

Without medical devices, it would be impossible to do regular medical procedures like bandaging a damaged ankle, diagnosing HIV/AIDS, implanting an artificial hip, or performing any type of surgery. Medical gadgets are utilized by laypeople at home, paramedical workers and clinicians at outlying clinics, optometrists, dentists, and healthcare professionals in cutting-edge medical facilities, for screening and prevention, as well as in palliative care. These medical technologies are employed in the diagnosis and treatment of acute and chronic illnesses, as well as in the support of persons with disabilities.

In today's healthcare, biomaterials are crucial. They are utilized in medical applications to improve, replace, or support damaged tissue or a biological function. They can be natural or synthetic. A biomaterial can be made from materials such as metals, ceramics, plastic, polymers, and even biological cells and tissues. They have a wide range of uses, including in drug delivery systems, medical implants (such as heart valves, stents, grafts, artificial joints, ligaments, and tendons), and ways to assist the healing of human tissues (such as sutures and clips). The prevalence of cardiovascular disorders is on the rise, implantable device demand is increasing, and governmental and non-governmental organizations are providing more funding for the development of innovative biomaterials, all of which are contributing factors to the market growth for these materials.

Market Size and Key Findings

The Europe Biomaterials in Healthcare Market size is at around US $ 31.3 Bn in 2021 and is projected to reach US $ 61.57 Bn in 2030, exhibiting a CAGR of 14.3% during the forecast period.

Europe Biomaterials in Healthcare Market Size (In $Bn) (2021-2030F)

Market Dynamic

Market Growth Drivers Analysis

Over the past few years, biomaterials have become more in demand and used in a variety of medical applications. The development of innovative biomaterials is being supported by investments, funding, and grants from a number of government agencies and academic institutions. For instance, Drexel University awarded the National Science Foundation $200,000 in March 2018 to support research on the impact of macrophage behaviour control by biomaterials on biomaterial vascularization. Such research and funding initiatives should encourage the creation of novel biomaterials, opening up a wide range of potential for the market's expansion.

Market Restraints

Before any new biomaterials can be approved for marketing, it must be shown that it is both safe and effective. The FDA has established tight criteria and restrictions for the approval procedure in the US. Implantable pacemakers, stents, and heart valves are examples of biomaterial-based goods that are categorized by the FDA as Class III devices, which are those that carry the greatest risk of sickness or harm. As a result, the premarket approval application procedure is used for these products (the most stringent type of device marketing application).

Competitive Landscape

Key Players

Key players in the biomaterials market include BASF SE, Covestro AG, Celanese Corporation, Corbion, Royal DSM, Evonik Industries, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., CoorsTek Inc., CeramTec, and Gelita AG

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Europe market in 2019. The growing geriatric population Europely is expected to drive growth for this segment.

  • Metallic Biomaterials
    • Stainless Steel
    • Titanium & Titanium Alloys
    • Cobalt-Chrome Alloys
    • Gold
    • Silver
    • Magnesium
  • Polymeric Biomaterials
    • Polymethylmethacrylate
    • Polyethylene
    • Polyester
    • Silicone Rubber
    • Nylon
    • Polyetheretherketone
    • Other Polymeric Biomaterials
  • Ceramics
    • Calcium Phosphate
    • Zirconia
    • Aluminum Oxide
    • Calcium Sulfate
    • Carbon
    • Glass
  • Natural Biomaterials
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin
    • Cellulose
    • Chitin
    • Alginates
    • Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

  • Cardiovascular
    • Catheters
    • Stents
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Sensors
    • Heart Valves
    • Vascular Grafts
    • Guidewires
    • Others
       
  • Orthopedic
    • Joint Replacement
      • Knee Replacement
      • Hip Replacement
      • Shoulder Replacement
      • Others
    • Viscosupplementation
    • Bioresorbable Tissue Fixation
    • Spine?
      • Spinal Fusion Surgeries
      • Minimally Invasive Fusion Surgeries
      • Motion Preservation & Dynamic Stabilization Surgeries
        • Pedicle-Based Rod Systems
        • Interspinous Spacers
        • Artificial Discs
    • Fracture Fixation Devices
      • Bone Plates
      • Screws
      • Pins
      • Rods
      • Wires
    • Synthetics Bone Grafts
       
  • Ophthalmology
    • Contact Lenses
      • Intraocular Lenses
      • Functional Replacement of Ocular Tissues
      • Synthetic Corneas
      • Others
  • Dental
    • Dental Implants
    • Dental Bone Grafts & Substitutes
    • Dental Membranes
    • Tissue Regeneration
       
  • Plastic Surgery
    • Soft-Tissue Fillers
    • Craniofacial Surgery
       
  • Wound Healing
    • Wound Closure Devices
      • Sutures
      • Staples
    • Surgical Hemostats
    • Internal Tissue Sealants
    • Adhesion Barriers
    • Hernia Meshes
       
  • Tissue Engineering
    • Scaffolds for Regenerative Medicine
    • Nanomaterials for Biosensing
    • Tailoring of Inorganic Nanoparticles
      ?
  • Neurological/Central Nervous System Applications
    • Shunting Systems
    • Cortical Neural Prosthetics
    • Hydrogel Scaffolds for CNS Repair
    • Neural Stem Cell Encapsulation
      ?
  • Other Applications
    • Drug Delivery Systems
    • Gastrointestinal Applications
    • Bariatric Surgery
    • Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 13 August 2024
Updated by: Bhanu Pratap Singh

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up